OPRM1 and irritable bowel syndrome: Historically, the first attempt to utilize the fentanyl scaffold for creating multitarget opioid/non-opioid compounds was the one in which researchers tried to obtain dual ligands for MOR and I2-imidazoline binding sites (I2-IBS) [26,27,28].